Netherlands : AEX Share Prices, AEX Indexes & News

AEX Index 802.17+1.2%

AMX Index 1,092.82+0.7%

AScX Index 1,385.71+1.0%

Euronext 100 Index 1,321.64+1.2%

Netherlands Stock Search

Look up ASE / Euronext Companies, Charts, News, Commodities, Forex and more

Unilever

46.72
-0.09
-0.19%

Royal Dutch Shell

17.83
+0.05
+0.28%

ING Group

11.70
+0.112
+0.97%

ArcelorMittal

25.97
+0.225
+0.87%

AEX Index

802.17
+9.77
+1.23%

AMX Index

1,092.82
+7.69
+0.71%

AScX Index

1,385.71
+14.04
+1.02%

Euronext 100

1,321.64
+15.51
+1.19%

EURONEXT Amsterdam Share Prices

Name Price Change %
Royal Dutch Shell17.83+0.28%
Unilever46.72-0.19%
ING Groep NV11.7+0.97%
ArcelorMittal25.965+0.87%
Koninklijke Philips NV40.155+1.40%
Koninklijke KPN NV2.78+0.22%
Ahold Kon
ASML Holding NV756.2+2.37%
Akzo Nobel NV98.6+0.80%
Heineken92.14+0.68%
Aegon N V4.056+0.12%
Koninklijke DSM NV186.45+1.03%
RELX26.03+0.42%
Wolters Kluwers NV97+0.79%
Gemalto51.2+0.00%
Fugro NV8.742+0.17%
Randstad NV60.34+0.80%
Tnt Express
PostNL NV4.335+1.38%
SBM Offshore NV15.175-0.10%
Air France KLM4.327+0.23%
Royal Boskalis Westminst...26.78+0.45%
Wereldhave NV12.78-0.47%
Aperam49.29+1.07%
Tomtom NV6.875+0.88%
Unibail-Rodamco (delisted)

Euro FOREX Rates

More FOREX
Name Price Change
EUR USD1.1728+0.0041
EUR JPY128.9775+0.6275
EUR GBP0.8581-0.0001
EUR AUD1.6103-0.0055
EUR CHF1.0844+0.0017
EUR CAD1.4863-0.0078
EUR HKD9.1293+0.0301
EUR SEK10.1370-0.0293
EUR NZD1.6633-0.0085
EUR KRW1,373.8700-8.3650
EUR SGD1.5810-0.0015
EUR NOK10.0847-0.0411

Commodities Prices

More Commodities
Name Market Price %
GoldCOMEX1,771.60-0.40%
SilverCOMEX25.83+0.00%
PlatinumNYMEX1,061.40+0.00%
CopperCOMEX4.27+0.33%
Brent Crude OilNYMEX76.15-0.05%
GasolineNYMEX2.14+0.00%
Natural GasNYMEX4.85-0.16%
Coffee ArabicaBMF223.45+1.34%

Euronext Amsterdam Market News

More Market News

Arecor's Insulin Candidate Achieves Positive Results in Phase 1 Trial

By Anthony O. Goriainoff Arecor Therapeutics PLC said Monday that its insulin candidate for diabetes, AT278, met all primary and secondary endpoints with positive headline results from the Phase 1 clinical trial. The London-listed biopharmaceutical company--backed by Unilever PLC--said AT278 had the potential to significantly improve post prandial glucose control and reduce the injection volume and/or number of daily injections of people with...

Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 09:50:04